CGEM (STOCKS)
Cullinan Therapeutics, Inc. Common Stock
$11.960000
-0.230000 (-1.89%)
Prev close: $12.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Nadim Ahmed
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $707.14M
- Employees
- 111
- P/E (TTM)
- -3.25
- P/B (TTM)
- 1.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $484.13M |
| Current Assets | $342.24M |
| Cash | $332.60M |
| Prepaid Expenses | $9.64M |
| Noncurrent Assets | $141.89M |
| Fixed Assets | $489.00K |
| Other Non-current Assets | $141.40M |
| Liabilities | $32.76M |
| Current Liabilities | $32.76M |
| Accounts Payable | $1.72M |
| Other Current Liabilities | $31.04M |
| Noncurrent Liabilities | $0.00 |
| Equity | $451.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $451.37M |
| Liabilities And Equity | $484.13M |